The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Investor's Business Daily on MSN3h
Is Larry Ellison Moderna's Saving Grace? Is Moderna Stock Now A Buy?
its Covid vaccine has yet to hit a bottom and its RSV vaccine is coming from behind in competition with Pfizer and GSK. To find the best stocks to buy and watch, check out IBD Stock Lists. Make sure ...